Cargando…
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
4-1BB agonist antibody treatment induces a population of KLRG1(+) T cells that infiltrate melanoma tumors. We investigated the origin and function of these cells, as well as their place within established T cell paradigms. We find that these T cells, particularly the CD4 lineage, represent a novel p...
Autores principales: | Curran, Michael A., Geiger, Theresa L., Montalvo, Welby, Kim, Myoungjoo, Reiner, Steven L., Al-Shamkhani, Aymen, Sun, Joseph C., Allison, James P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620352/ https://www.ncbi.nlm.nih.gov/pubmed/23547098 http://dx.doi.org/10.1084/jem.20121190 |
Ejemplares similares
-
Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production
por: Curran, Michael A., et al.
Publicado: (2011) -
Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy
por: Song, Chang, et al.
Publicado: (2014) -
Global identification of Smad2 and Eomesodermin targets in zebrafish identifies a conserved transcriptional network in mesendoderm and a novel role for Eomesodermin in repression of ectodermal gene expression
por: Nelson, Andrew C, et al.
Publicado: (2014) -
Regulation of CD4 T Cell Responses by the Transcription Factor Eomesodermin
por: Dhume, Kunal, et al.
Publicado: (2022) -
Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation
por: Raveney, Ben J. E., et al.
Publicado: (2015)